Raising the Bar in the Diagnosis of Non-Small Cell Lung Cancer (NSCLC): The Impact of Automated FISH Technology

Line Emilie Boje Zakariasen, Mary Mathilde Knoblauch Fasting, Sys Johnsen, Svetlana Teplaia, Sanni Charlotte Pedersen, Filis Cramer Necip, Camilla Qvist

    Publikation: Bidrag til tidsskriftTidsskriftsartikelForskningpeer review

    Abstract

    The Met gene, which encodes a receptor tyrosine kinase, is crucial in cancer cell proliferation and survival. Fluorescence in situ hybridization (FISH) is vital for assessing MET-gene amplification in non-small cell lung cancer (NSCLC). Manual FISH assays are time-consuming and results are critical for treatment decision; automation could reduce turnaraound time. This study evaluates the potentional benefits of the automated FISH-system, Oncore Pro X (biocare Medical USA), by assessing factors including results, turnaround time, and cost.
    OriginalsprogEngelsk
    TidsskriftInternational Journal of Biomedical Laboratory Science
    Vol/bind14
    Udgave nummer1
    Sider (fra-til)24-38
    ISSN2308-7706
    StatusUdgivet - 2025

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Raising the Bar in the Diagnosis of Non-Small Cell Lung Cancer (NSCLC): The Impact of Automated FISH Technology'. Sammen danner de et unikt fingeraftryk.

    Citationsformater